++
Chapter 11. Comparative Effectiveness
++
++
++
Which of the following is NOT an example of comparative effectiveness research?
++
++
++
A. An observational study using propensity matching
++
++
++
++
C. An efficacy-based randomized control trial
++
++
D. A decision tree–based analytical study
++
++
++
What is one of the weaknesses related to meta-analyses?
++
++
++
A. They combine information from across multiple studies
++
++
B. Most of the data available will be efficacy data, not data on effectiveness
++
++
C. Similar endpoints from multiple studies are used to generate a combined effect size
++
++
D. They are not well accepted
++
++
++
Which of these is NOT a strength of observational studies?
++
++
++
A. Their longitudinal nature or ability for researchers to follow patients over very long periods of time that are most often contiguous
++
++
B. Their ready availability at little expense
++
++
C. Their ability to control for selection bias with randomization of subjects
++
++
D. Their ability to answer research questions that cannot be answered with RCTs such as effects of changes in policy or clinical practice
++
++
++
A stochastic decision analysis model is
++
++
++
A. A statistical approaches used to analyzed data to identify patterns of relationships between variables and to test hypotheses.
++
++
B. Mathematical structures that are used to link evidence from multiple sources to predict outcomes such as effectiveness, costs, or cost effectiveness often over a long time period.
++
++
C. A method used to control selection bias.
++
++
D. A way to assess the efficacy of treatment effect in clinical trials.
++
++
++
Which of these is NOT a type of propensity score method?
++
++
++
++
++
++
++
++
++
++
++
++
++
++
++
A. A systematic error that can affect the integrity of a study (internal validity), causing some members of the population to be less likely to be included than others in the study sample
++
++...